• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    InCarda Therapeutics Announces RESTORE-1 Ph 3 Trial Results

    BUSINESSWIRE

    InCarda terminates its PhIII trial for arrhythmia drug

    ENDPTS

    InCarda, PhysIQ and Syneos team for phase 3 flecainide study

    FIERCEBIOTECH

    physIQ Announces Collaboration with InCarda Therapeutics and Syneos Health

    BUSINESSWIRE

    InCarda Therapeutics Provides Corporate Update

    BIOSPACE

    InCarda Therapeutics Provided Corporate Update

    GLOBENEWSWIRE

    InCarda unrolls mid-stage data backing inhaled arrhythmia drug

    ENDPTS

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.